Glucokinase gene locus transgenic mice are resistant to the development of obesity-induced type 2 diabetes

Diabetes

Volumn 50, Issue 3, 2001, Pages 622-629

  Shiota, Masakazu ^a   Postic, Catherine ^a   Fujimoto, Yuka ^a   Jetton, Thomas L ^a   Dixon, Kathryn ^a   Pan, Danhua ^a   Grimsby, Joseph ^b   Grippo, Joseph F ^b   Magnuson, Mark A ^a   Cherrington, Alan D ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b HOFFMANN LA ROCHE INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOHYDRATE; GLUCOKINASE; GLUCOSE; INSULIN;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARBOHYDRATE METABOLISM; DIET RESTRICTION; DISEASE ASSOCIATION; ENZYME ACTIVITY; FEEDING; GENE LOCUS; GENE MUTATION; GENE OVEREXPRESSION; GLUCONEOGENESIS; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HYPERGLYCEMIA; HYPERINSULINEMIA; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PRIORITY JOURNAL; TRANSGENIC MOUSE;

EID: 0035123353     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.50.3.622     Document Type: Article

References (79)

1. Pathogenesis of NIDDM: A balanced overview
2. Hepatic and peripheral insulin resistance: A common feature of type 2 (non-insulin-dependent) and type 1 (insulin-dependent) diabetes mellitus
3. From obesity to diabetes: Pathophysiological considerations
4. Disordered metabolism in diabetes: Have we underemphasized the fat component?
5. Hepatic glucose production in insulin-resistant states
6. Liver metabolism in diabetes
7. The effect of chronic sulfonylurea therapy on hepatic glucose production in non-insulin-dependent diabetes
8. Quantification of the relative impairment in actions of insulin on hepatic glucose production and peripheral glucose uptake in non-insulin-dependent diabetes mellitus
9. Fasting hyperglycemia in non-insulin-dependent diabetes mellitus: Contributions of excessive hepatic glucose production and impaired glucose uptake
10. Contribution to postprandial hyperglycemia and effect on initial splanchnic glucose clearance of hepatic glucose cycling in glucose-intolerance or NIDDM patients
11. Predominant role of gluconeogenesis in increased hepatic glucose production in NIDDM
12. Contribution of abnormal muscle and liver glucose metabolism to postprandial hyperglycemia in NIDDM
13. Increased lipolysis and its consequence on gluconeogenesis in non-insulin-dependent diabetes mellitus
14. 13C nuclear magnetic resonance study
15. Lipolysis and gluconeogenesis from glycerol are increased in patients with noninsulin-dependent diabetes mellitus
16. Postprandial hyperglycemia in patients with noninsulin dependent diabetes mellitus: Role of hepatic and extrahepatic tissues
17. Minimal model analysis of intravenous glucose tolerance test-derived insulin sensitivity in diabetic subjects
18. Impaired postprandial glucose utilization in non-insulin dependent diabetes mellitus
19. Levels of translatable mRNA coding for rat liver glucokinase
20. 13C nuclear magnetic resonance spectroscopy study
21. 13C-nuclear magnetic resonance spectroscopy studies of hepatic glucose metabolism in normal subjects and subjects with insulin-dependent diabetes mellitus
22. Liver and muscle insulin sensitivity, glycogen concentration and glycogen synthase activity in a rat model of non-insulin-dependent diabetes
23. Regulation of hepatic glycogen metabolism: Effects of diabetes, insulin infusion, and pancreatic islet transplantation
24. The biochemical basis of increased hepatic glucose production in a mouse model of type 2 (non-insulin-dependent) diabetes mellitus
25. Predominant role of gluconeogenesis in the hepatic glycogen repletion of diabetic rats
26. Increased hepatic glucose production and decreased hepatic glucose uptake at the prediabetic phase in the Otsuka Long-Evans Tokushima fatty rat model
27. Relative contribution of glycogenolysis and gluconeogenesis to hepatic glucose production in control and diabetic rats: A re-examination in the presence of euglycaemia
28. Transgenic knockouts reveal a critical requirement for pancreatic β cell glucokinase in maintaining glucose homeostasis
29. Animal model for maturity-onset diabetes of the young generated by disruptions of the mouse glucokinase gene
30. Abnormal regulation of HGP by hyperglycemia in mice with a disrupted glucokinase allele
31. Glucosamine-induced inhibition of liver glucokinase impaired the ability of hyperglycemia to suppress endogenous glucose production
32. Dual roles for glucokinase in glucose homeostasis as determined by liver and pancreatic β-cell specific gene knock-outs using Cre recombines
33. Effects of increased glucokinase gene copy number on glucose homeostasis and hepatic glucose metabolism
34. Correction of diabetic alterations by glucokinase
35. Evidence from transgenic mice that glucokinase is rate limiting for glucose utilization in the liver
36. Expression of human hepatic glucokinase in transgenic mice liver results in decreased glucose levels and reduced body weight
37. Metabolic impact of glucokinase overexpression in liver: Lowering of blood glucose in fed rats is accompanied by hyperlipidemia
38. Stimulation by insulin of glucokinase gene transcription in liver of diabetic rats
39. Rapid action of insulin and cyclic AMP in the regulation of functional messenger RNA coding for glucokinase in rat liver
40. Evidence that GLUT-2 mRNA and protein concentration are decreased by hyperinsulinemia and increased by hyperglycemia in liver of diabetic rats
41. Impaired hepatic glycogen synthesis in glucokinase-deficient (MODY-2) subject
42. Lincage of type 2 diabetes to the glucokinase gene
43. Primary pancreatic β-cell secretory defect caused by mutations in the glucokinase in kindreds of maturity onset diabetes of the young
44. Familial hyperglycemia due to mutations in glucokinase: Definition of a subtype of diabetes mellitus
45. Insulin secretory abnormalities in subjects with hyperglycemia due to glucokinase mutations
46. Liver glucokinase: Decreased activity in patients with type II diabetes
47. Regulation of endogenous glucose production by glucose per se is impaired in type 2 diabetes mellitus
48. Glucose regulates in vivo glucose-6-phosphatase gene expression in the liver of diabetic rats
49. Regulation of rat liver glucose-6-phosphatase gene expression in different nutritional and hormonal states: Gene structure and 5′-flanking infusion
50. Induction of hepatic glucose-6-phosphatase gene expression by lipid infusion
51. Stimulation of glucose-6-phosphatase gene expression by glucose and fructose-2,6-bisphosphate
52. Role of glucokinase and glucose-6-phosphatase in the acute and chronic regulation of hepatic glucose flux by insulin
53. Metabolic effects of short-term fasting in obese hyperglycemic humans and mice
54. Diet-induced type II diabetes in C57BL/6J
55. Nongenetic mouse models of non-insulin-dependent diabetes mellitus
56. Cell-specific expression and regulation of a glucokinase gene locus transgene
57. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
58. Cloning and characterization of the mouse glucokinase gene locus and identification of distal liver-specific DNase I hypersensitive sites
59. Rat glucokinase gene: Structure and regulation by insulin
60. p1B15: A cDNA clone of the rat mRNA encoding cyclophilin
61. Glycogen
62. Diet-induced hypercholesterolemia in mice: Prevention by overexpression of LDL receptor
63. Short-term regulation of glucokinase
64. Glucokinase regulatory protein may interact with glucokinase in the hepatocyte nucleus
65. Intracellular binding of glucokinase in hepatocytes and translocation by glucose, fructose, and insulin
66. Characterization of glucokinase regulatory protein-deficient mice
67. Mice mutant for glucokinase regulatory protein exhibit decreased liver glucokinase: A sequestation mechanism in metabolic regulation
68. Perturbation of fuel homeostasis caused by overexpression of the glucose-6-phosphatase catalytic subunit in liver of normal rats
69. Correction of hyperglycemia with phlorizin restores the glucagon response o glucose in insulin-deficient dogs; implication for human diabetes
70. Hyperglycemia as an inducer as well as a consequence of impaired islet cell function and insulin resistance: Implication for the management of diabetes
71. Partial pancreatectomy in the rat and subsequent defect in glucose induced insulin release
72. Abnormalities of insulin responses after ambient and previous exposure to glucose in streptozocin-diabetic and dexamethasonetreated rats: Role of hyperglycemia and β-cell demands
73. Effect of chronic hyperglycemia on in vivo insulin secretion in partially pancreatectomized rats
74. Correction of hyperglycemia with phlorizin normalizes tissue sensitivity to insulin in diabetic rats
75. Glucokinase as glucose sensor and metabolic signal generator in pancreatic β-cells and hepatocytes
76. Potentiated β-cell response to non-glucose stimuli in insulin-resistant C57BL/6J mice
77. Mechanism of fat-induced attenuation of glucose-induced insulin secretion from mouse pancreatic islets
78. The biochemistry of the complications of diabetes mellitus
79. Relation of metabolic control of diabetes mellitus to chronic complications